ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LUMO Lumos Pharma Inc

2.96
-0.08 (-2.63%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Lumos Pharma Inc LUMO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.08 -2.63% 2.96 08:11:55
Open Price Low Price High Price Close Price Previous Close
3.05 2.90 3.05 2.96 3.04
more quote information »

Recent News

Date Time Source Heading
19/4/202406:05GLOBELumos Pharma Announces Abstracts Accepted for Presentation..
20/3/202423:00GLOBELumos Pharma Announces that the USPTO Has Granted Patent..
08/3/202408:48EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202408:44EDGAR2Form 8-K - Current report
08/3/202408:01GLOBELumos Pharma Reports Full Year 2023 Financial Results and..
27/2/202401:00GLOBELumos Pharma to Report Full Year 2023 Financial Results and..
08/2/202409:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202408:02EDGAR2Form 144 - Report of proposed sale of securities
06/2/202409:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202409:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202409:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202409:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202409:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202408:05GLOBELumos Pharma to Participate in Oppenheimer’s 34th Annual..
11/1/202411:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/1/202408:34EDGAR2Form 8-K - Current report
05/1/202408:05GLOBELumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to..
30/11/202308:30EDGAR2Form SC 13D/A - General statement of acquisition of..
22/11/202308:15GLOBELumos Pharma to Host Virtual Key Opinion Leader Webinar to..
21/11/202308:05GLOBELumos Pharma Announces Participation in the Piper Sandler..
16/11/202308:38EDGAR2Form 8-K - Current report
08/11/202310:24DJNLumos Pharma Shares Than Double After Hormone Deficiency..
08/11/202309:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202308:42EDGAR2Form 8-K - Current report
08/11/202308:35GLOBELumos Pharma Reports Third Quarter 2023 Financial Results..
08/11/202308:08EDGAR2Form 8-K - Current report
08/11/202308:01GLOBELumos Pharma Announces Topline Data from Phase 2..
27/9/202306:34EDGAR2Form 8-K - Current report
26/9/202323:00GLOBELumos Pharma Announces New Data and Analysis of 15 Subjects..
14/9/202322:00GLOBELumos Pharma Announced Abstract Accepted for Oral..
08/9/202306:34GLOBELumos Pharma Announces Participation in Investor Conferences..
22/8/202323:00GLOBEIndependent Panel of Renowned Pediatric Endocrinologists to..
10/8/202323:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:36EDGAR2Form 8-K - Current report
10/8/202306:01GLOBELumos Pharma Reports Second Quarter 2023 Financial Results,..
04/8/202306:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202306:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202305:54EDGAR2Form 144 - Report of proposed sale of securities
26/7/202323:00GLOBELumos Pharma to Report Second Quarter 2023 Financial Results..
12/7/202322:00GLOBELumos Pharma to Participate in the Oppenheimer 2023 Montauk..
29/6/202306:26EDGAR2Form 8-K - Current report
29/6/202306:01GLOBELumos Pharma Announces Departure of Chief Medical Officer
21/6/202323:00GLOBELumos to Highlight New LUM-201 Data and Analysis Presented ..
31/5/202322:00GLOBELumos Pharma to Participate in the Upcoming 2023 BIO..
25/5/202322:00GLOBELumos Pharma Announces Abstracts Accepted for Oral..
22/5/202323:00GLOBELumos Pharma to Participate in World Orphan Drug Congress..
08/5/202322:00GLOBEEncouraging Data from Lumos Pharma OraGrowtH Trials..

Your Recent History

Delayed Upgrade Clock